Rovellasca, Italy

Danilo Moltrasio


Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 1997-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Inventor Danilo Moltrasio

Introduction

Danilo Moltrasio is a notable inventor based in Rovellasca, Italy. With a strong focus on advancements in pharmaceuticals, he has contributed significantly to the field with his inventive prowess. Moltrasio holds a commendable total of three patents, showcasing his dedication to innovation.

Latest Patents

Moltrasio's latest patents reflect his commitment to addressing vital health issues. One of his patents concerns "Agents and compositions thereof for the hair treatment," a formulation designed to enhance the health and aesthetics of hair. In addition, he has developed a treatment aimed at "cardiac ischemia by administration of a fraction of oligodeoxyribonucleotides of animal origin." These oligodeoxyribonucleotides, with a molecular weight ranging between 4000 and 10000 daltons, exhibit significant anti-ischemic activity, demonstrating the potential to improve cardiac health through innovative biochemical approaches.

Career Highlights

Danilo Moltrasio is currently affiliated with Crinos Industria Farmacobiologica S.p.A., a company known for its advancements in pharmacobiological products. His position within the organization underscores his influence in the pharmaceutical sector and showcases his continuous drive to improve therapeutic solutions.

Collaborations

In his professional journey, Moltrasio has collaborated with esteemed colleagues, including Roberto Porta and Ennio Lanzarotti. These partnerships highlight the spirit of teamwork in research and development, contributing to more dynamic and impactful innovations.

Conclusion

In summary, Danilo Moltrasio is a distinguished inventor whose patent contributions are making a significant impact in the realm of health and pharmaceuticals. His latest innovations continue to advance treatment options for critical health conditions while promoting collaboration and creativity in the research community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…